Horvath, Dennis
Temperton, Nigel
Mayora-Neto, Martin
Da Costa, Kelly
Cantoni, Diego
Horlacher, Reinhold
Günther, Armin
Brosig, Alexander
Morath, Jenny
Jakobs, Barbara
Groettrup, Marcus
Hoschuetzky, Heinz
Rohayem, Jacques
ter Meulen, Jan
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC2117-422037984)
Philipps-Universität Marburg
Article History
Received: 7 November 2022
Accepted: 8 March 2023
First Online: 21 March 2023
Competing interests
: RH, JR and JtM are inventors on a patent application relating to a M-cell targeted SARS-CoV-2 and H1-influenza virus vaccine. DH, NT, MMN, KDC, DC, AG, AB, JM, BJ, MG, and HH declare no conflict of interest.